載入...
Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
BACKGROUND: Myxoid liposarcoma is a histological subtype of liposarcoma particularly sensitive to trabectedin. In clinical use this drug does not cause cumulative toxicity, allowing prolonged treatment, generally until disease progression. No other effective therapies are available for trabectedin-r...
Na minha lista:
| 發表在: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6738121/ https://ncbi.nlm.nih.gov/pubmed/31409911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0550-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|